Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms

J Trauma Acute Care Surg. 2020 Dec;89(6):e177-e181. doi: 10.1097/TA.0000000000002938.

¹ From the Department of Medicine (C.H.Y.), Division of Emergency Medicine, University of Toronto, Toronto; Thrombosis and Atherosclerosis Research Institute (C.H.Y., J.I.W., N.V., P.C.L., A.F.-R., P.Y.K.), Hamilton; Department of Critical Care (C.H.Y., K.S.), Lakeridge Health Corporation, Oshawa; Department of Medicine (K.d.W., J.I.W., P.C.L., A.F.-R., P.Y.K.), McMaster University, Hamilton, Ontario, Canada; Department of Anesthesiology (J.H.L.), Critical Care, and Surgery, Duke University School of Medicine, Durham, North Carolina; Department of Biochemistry and Biomedical Sciences (J.I.W.), McMaster University, Hamilton; and Department of Critical Care Medicine (K.S.), Queen's University, Kingston, Ontario, Canada.

No abstract available

Publication types